NDDTE'22 Keynote Lecture

April 05| 8:15 AM - 9:00 AM | Session Chair: Dr. Wolfgang Ensinger, Technische Universität Darmstadt, Germany

Advances in Nucleic Acid Medicine Delivery to the Brain
Dr. Moein Moghimi, Newcastle University, UK

Moein Moghimi is a Professor of Pharmaceutics and Nanomedicine at the School of Pharmacy, and Translational and Clinical Research Institute, Newcastle University (UK), and an Adjoint Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-Denver. He is also co-founder of three spin-offs in USA and UK, and Associate Editor of Molecular Therapy (Cell Press). He graduated with Honors in Biochemistry from the University of Manchester (UK) in 1985 and then completed a PhD in Biochemistry at Charing Cross and Westminster Medical School (Imperial College, London).

Moghimi is widely recognised for his contribution to fundamental and translational research in nanomedicine and drug delivery, especially in mechanistic understanding of nanoparticle-mediated complement activation and infusion reactions, and as an inventor of many nanosystems for tissue-specific targeting. The latter have included “splenotropic” and “lymphotropic” nanoparticles. Among the latest inventions of Moghimi’s laboratory are the NanoLigand Carriers. These are induced self-assemblies of phage-derived display peptides that on intravenous injection rapidly target two receptors on the blood brain-barrier, reaching neurons and microglia. A 2021 study by Stanford University list Moghimi among the top 0.08% of world’s leading scientists across in all fields, and rank him at 53 (out of 131,063) in the field of pharmacology in the world and 28 in Europe. As to date, Moghimi’s research programme has secured over €25 million funding. He is widely published (>300 research papers, reviews, book chapters, proceedings, etc., ORCID: 0000-0003-0836-926X) and cited (>24,000 citations and h-index of 70, GS as of Jan 2022), and has delivered >400 invited plenaries, keynote speeches and distinguished lectures world-wide. He also serves on editorial board of >10 international journals including Advanced Drug Delivery Reviews, Journal of Controlled Release and Nanomedicine (Lond.). He is also an active consultant to industry and governmental organisations.

Keynote Lecture

April 05| 9:00 AM - 9:45 AM | Session Chair: Dr. Wolfgang Ensinger, Technische Universität Darmstadt, Germany

Heteroatom-Doped Carbon Quantum Dots as Electrocatalysts for the Oxygen Reduction Reaction
Dr. Philippe Knauth, Aix Marseille Université, France

Currently Professor of Materials Chemistry and Director of the Chemistry Department at Aix Marseille University. Obtained his PhD in Physical Chemistry (Dr. rer. nat., Saarland University) in 1987 and the Habilitation in Materials Science (Aix Marseille University) in 1996. Prior to becoming a Full Professor in 1999, hold different positions: post-doctoral fellow (CNRS, Centre de Thermodynamique et de Microcalorimétrie, 1987-1989), laboratory head at Bayer Co. (Pigments and Ceramics Division, 1989-1990) and CNRS researcher (“Chargé de Recherche“, 1990-1999). Member of the Editorial Board of several international journals: “Journal of Electroceramics” (Springer), “Journal of Nanomaterials” (Hindawi), “Frontiers in Energy Research” and “Membranes” (MDPI). Société Chimique de France (SCF): Vice-President (2006-2010) and President (2010-2017) of the “Provence-Alpes-Cote d’Azur” regional section and member of the Administration Council (Board of Directors) of SCF (representing the regional sections 2012-2017).

HIUPAC: National Representative 2015-2019 and Titular Member since 2019 (Division II: Inorganic Chemistry). Appointed visiting scholar at MIT in 1997-98 and 2013 and Invited professor at the National Institute of Materials Science (Tsukuba, Japan) in 2007 and 2010 and at the University of Rome Tor Vergata in 2009, 2011 and 2022.

Session

April 05| 9:55 AM - 10:45 PM | Session Chair: Dr. Wolfgang Ensinger, Technische Universität Darmstadt, Germany

Nanotechnology and Drug Delivery I

Session

April 05| 10:45 AM - 12:15 PM | Session Chair: Dr. Marta Sevieri, Università degli Studi di Milano, Italy & Dr. María del Mar Collado González, University of Murcia, Spain

Nanomaterials Applications

ICNNFC'22 Keynote Lecture

April 05| 12:45 PM - 1:30 PM | Session Chair: Dr. Josef Jampilek, Comenius University, Slovakia

The Role of the Biomolecule Corona in Determining Biocompatibility of Nanoscale Materials
Dr. Iseult Lynch, University of Birmingham, UK

Professor Iseult Lynch undertook her PhD in Physical Chemistry at University College Dublin developing responsive polymeric materials for use in medical devices and as tissue growth substrates. She subsequently did several years of postdoctoral research at Physical Chemistry 1, Lund University in Sweden, including as an EU Marie Curie Fellow, investigating several aspects of colloid and interface science and biophysics. She returned to University College Dublin in 2006 where she led the nanoparticle synthesis and bio-characterisation group at the Centre for BioNano Interactions (CBNI). She then became the Strategic Research Manager for CBNI, and was instrumental in securing multiple large scale national and EU funding bids. In March 2013 she joined the University of Birmingham as a Lecturer in Environmental Nanosciences, becoming Senior Lecturer in 2015 and Professor of Environmental Nanosciences in 2016.

Session

April 05| 1:30 PM - 02:00 PM | Session Chair: Dr. Sergej Tomić, Institute for the Application of Nuclear Energy, Serbia

Detecting and Monitoring of Nanomaterials I

Session

April 05| 2:00 PM - 02:40 PM | Session Chair: Dr. Marta Sevieri, Università degli Studi di Milano, Italy & Dr. María del Mar Collado González, University of Murcia, Spain

Nanotechnology: Modeling and Simulation